ACTG shareholder plans sale of 85,827 shares

An affiliate of ACTG filed notice of a proposed disposition of common stock.

Rhea-AI Filing Summary

An affiliate of ACTG filed notice of a proposed disposition of common stock. The plan covers up to 85,827 shares of common stock to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an approximate aggregate market value of $395,181.84 and an approximate sale date of August 11, 2026. The shares relate to restricted stock grants dated May 26, 2024, June 7, 2025, and May 30, 2026.

Key Figures

Shares to be sold: 85,827 shares Aggregate market value: $395,181.84 Approximate date of sale: 08/11/2026 +3 more

6 metrics

Shares to be sold 85,827 shares Planned disposition of ACTG common stock under Form 144

Aggregate market value $395,181.84 Approximate market value of ACTG shares covered by the Form 144

Approximate date of sale 08/11/2026 Expected start date for sales of ACTG common stock

Restricted stock grant 1 30,534 shares Common stock from 05/26/2024 restricted stock grant

Restricted stock grant 2 23,121 shares Common stock from 06/07/2025 restricted stock grant

Restricted stock grant 3 32,172 shares Common stock from 05/30/2026 restricted stock grant

Key Terms

Form 144, Restricted Stock, aggregate market value, approximate date of sale

4 terms

Form 144 regulatory

"An affiliate of ACTG filed notice of a proposed disposition under Form 144."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"The shares relate to restricted stock grants dated May 26, 2024, June 7, 2025, and May 30, 2026."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

aggregate market value financial

"with an approximate aggregate market value of $395,181.84 and an approximate sale date"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

approximate date of sale regulatory

"with an approximate aggregate market value of $395,181.84 and an approximate sale date of August 11, 2026."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ACTG's Form 144 filing disclose?

The Form 144 discloses a proposed disposition of up to 85,827 shares of ACTG common stock, with an approximate aggregate market value of $395,181.84, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many ACTG shares are planned to be sold and at what value?

The filing indicates a plan to sell 85,827 shares of ACTG common stock with an approximate aggregate market value of $395,181.84, based on the market price used in the filing for Form 144 purposes.

When is the approximate date of sale for the ACTG shares in this Form 144?

The approximate date of sale for the ACTG common stock referenced in the Form 144 is August 11, 2026. This date reflects when the filer expects to begin sales under the proposed transaction.

Through which broker will the ACTG Form 144 shares be sold?

The planned sale of ACTG common stock will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as identified in the filing.

What types of ACTG awards are underlying the Form 144 shares?

The shares in ACTG's Form 144 are tied to Restricted Stock awards from the issuer, with grant dates of 05/26/2024, 06/07/2025, and 05/30/2026, each contributing separate blocks of shares to the total planned disposition.

How many ACTG shares from each restricted stock grant are included in the Form 144?

The Form 144 includes 30,534 shares from the 05/26/2024 grant, 23,121 shares from the 06/07/2025 grant, and 32,172 shares from the 05/30/2026 grant, totaling 85,827 shares of ACTG common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2026 - 05:04 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001247434
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ACACIA RESEARCH CORPORATION
SEC File Number	001-37721
Address of Issuer	777 Third Avenue, 26th Floor New York NEW YORK 10017
Phone	(332) 236-8500
Name of Person for Whose Account the Securities are To Be Sold	GEOFFREY RIBAR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	85827	395181.84	97586805	08/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/26/2024	Restricted Stock	Issuer			30534	05/26/2024	Not Applicable
Common	06/07/2025	Restricted Stock	Issuer			23121	06/07/2025	Not Applicable
Common	05/30/2026	Restricted Stock	Issuer			32172	05/30/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Geoffrey George Ribar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)